Health News

Monday, April 7, 2014 - 10:34

DIPGs are known as one of the most challenging tumours to treat because cancer cells are intimately intermingled with normal brain cells in a part of the brain that cannot be surgically resected. They are most commonly diagnosed in children between the ages of five and nine and account for 10 to 15 percent of all pediatric central nervous system tumours.


Monday, April 7, 2014 - 08:09

Motor neuron disease or central nervous system injury can lead to loss of essential voluntary muscle activity such as speaking, walking, breathing, and swallowing due to defects in motor neurons. A new study published on 4th April in the journal Science describes a method for bypassing the defective central motor circuit using engrafted, light-activated motor neurons. The study in mice was led by researchers in University College London (UCL) and King’s College London and offers hope for treatment of paralysis and breathing difficulties in these devastating conditions.


Monday, April 7, 2014 - 07:50

Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.


Friday, April 4, 2014 - 08:48

A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.


Friday, April 4, 2014 - 08:31

Drinking two cups of coffee per day substantially reduces risk of death from non-viral hepatitis related liver cirrhosis. This is the main finding of a study from researchers in the USA and Singapore as part of The Singapore Chinese Health Study. The study is published in the journal Hepatology.


Friday, April 4, 2014 - 08:26

For the first time, focused ultrasound was successfully used in the treatment of a brain tumor.  The adult patient had a recurrent glioma, a portion of which was thermally ablated through the intact skull using InSightec's Exablate Neuro system. The procedure was performed to assess the feasibility and safety of focused ultrasound in treating brain tumors; it was not intended to demonstrate efficacy.